Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11560926rdf:typepubmed:Citationlld:pubmed
pubmed-article:11560926lifeskim:mentionsumls-concept:C2700455lld:lifeskim
pubmed-article:11560926lifeskim:mentionsumls-concept:C0338451lld:lifeskim
pubmed-article:11560926lifeskim:mentionsumls-concept:C0242422lld:lifeskim
pubmed-article:11560926lifeskim:mentionsumls-concept:C0008659lld:lifeskim
pubmed-article:11560926lifeskim:mentionsumls-concept:C0002345lld:lifeskim
pubmed-article:11560926lifeskim:mentionsumls-concept:C1947976lld:lifeskim
pubmed-article:11560926lifeskim:mentionsumls-concept:C1947974lld:lifeskim
pubmed-article:11560926lifeskim:mentionsumls-concept:C1704666lld:lifeskim
pubmed-article:11560926lifeskim:mentionsumls-concept:C1517892lld:lifeskim
pubmed-article:11560926lifeskim:mentionsumls-concept:C0208973lld:lifeskim
pubmed-article:11560926lifeskim:mentionsumls-concept:C1720655lld:lifeskim
pubmed-article:11560926pubmed:issue46lld:pubmed
pubmed-article:11560926pubmed:dateCreated2001-11-12lld:pubmed
pubmed-article:11560926pubmed:abstractTextMutations in the human tau gene cause frontotemporal dementia and Parkinsonism associated with chromosome 17 (FTDP-17). One of the major disease mechanisms in FTDP-17 is the increased inclusion of tau exon 10 during pre-mRNA splicing. Here we show that modified oligonucleotides directed against the tau exon 10 splice junctions suppress inclusion of tau exon 10. The effect is mediated by the formation of a stable pre-mRNA-oligonucleotide hybrid, which blocks access of the splicing machinery to the pre-mRNA. Correction of tau splicing occurs in a tau minigene system and in endogenous tau RNA in neuronal pheochromocytoma cells and is specific to exon 10 of the tau gene. Antisense oligonucleotide-mediated exclusion of exon 10 has a physiological effect by increasing the ratio of protein lacking the microtubule-binding domain encoded by exon 10. As a consequence, the microtubule cytoskeleton becomes destabilized and cell morphology is altered. Our results demonstrate that alternative splicing defects of tau as found in FTDP-17 patients can be corrected by application of antisense oligonucleotides. These findings provide a tool to study specific tau isoforms in vivo and might lead to a novel therapeutic strategy for FTDP-17.lld:pubmed
pubmed-article:11560926pubmed:languageenglld:pubmed
pubmed-article:11560926pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11560926pubmed:citationSubsetIMlld:pubmed
pubmed-article:11560926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11560926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11560926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11560926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11560926pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11560926pubmed:statusMEDLINElld:pubmed
pubmed-article:11560926pubmed:monthNovlld:pubmed
pubmed-article:11560926pubmed:issn0021-9258lld:pubmed
pubmed-article:11560926pubmed:authorpubmed-author:MisteliTTlld:pubmed
pubmed-article:11560926pubmed:authorpubmed-author:MabonS ASAlld:pubmed
pubmed-article:11560926pubmed:authorpubmed-author:KalbfussBBlld:pubmed
pubmed-article:11560926pubmed:issnTypePrintlld:pubmed
pubmed-article:11560926pubmed:day16lld:pubmed
pubmed-article:11560926pubmed:volume276lld:pubmed
pubmed-article:11560926pubmed:ownerNLMlld:pubmed
pubmed-article:11560926pubmed:authorsCompleteYlld:pubmed
pubmed-article:11560926pubmed:pagination42986-93lld:pubmed
pubmed-article:11560926pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:meshHeadingpubmed-meshheading:11560926...lld:pubmed
pubmed-article:11560926pubmed:year2001lld:pubmed
pubmed-article:11560926pubmed:articleTitleCorrection of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.lld:pubmed
pubmed-article:11560926pubmed:affiliationNational Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.lld:pubmed
pubmed-article:11560926pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11560926lld:pubmed